Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Agile Sciences claims its naturally-sourced compounds could reinvigorate the use of antibiotics against drug-resistant bacterial infections. Malcolm Thomas – chief executive of the Raleigh, North Carolina-based start-up – told Animal Pharm editor Joseph Harvey how the company's technology might impact the animal health sector.
Elanco has said it is prepared for off-patent competition, after Huvepharma was recently given the green light by the US FDA for the first generic monensin for certain indications in cattle and goats.
The US FDA has handed a supplemental approval to Merck Animal Health for its Estrumate (cloprostenol injection) reproductive injectable for cows.
Cemile Jakupoglu of Cyton Germany and Maggie Fisher of the UK's Veterinary Research Management give Animal Pharm an overview of the major changes involved in the revised EU guideline on the conduct of bioequivalence studies for veterinary medicinal products, which came into play this year.
The UK's National Office of Animal Health (NOAH) has found Boehringer Ingelheim to be in breach of code on its promotion of a cattle vaccine.
Kindred Biosciences chief executive Richard Chin has said the firm is aiming to launch its monoclonal antibody candidate against canine parvovirus by the end of 2020 or early 2021.
Industry body Animal Medicines Australia (AMA) has added its 10th member – Troy Laboratories.
Dechra Pharmaceuticals has signed an intellectual property licensing and supply agreement for an insulin-based product candidate that it believes could become a top-seller in its portfolio.
Kindred Biosciences has once again seen its quarterly net loss increase, as it continues to advance its pipeline.
The US FDA has authorized additional indications for Syndel's 35% PEROX-AID – an over-the-counter treatment for freshwater finfish.
Zoetis has signaled a different approach to collaboration with academia by preparing to create a research laboratory at Colorado State University (CSU).
The University of Pennsylvania School of Veterinary Medicine (Penn Vet) will lead a clinical trial to assess whether a hemp-based natural supplement can relieve symptoms of joint immobility in dogs.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.